Literature DB >> 10986212

Immune reaction against the cytoskeleton in coeliac disease.

M G Clemente1, M P Musu, F Frau, G Brusco, G Sole, G R Corazza, S De Virgiliis.   

Abstract

BACKGROUND: The cytoskeleton actin network of intestinal microvilli has been found to be rapidly impaired after gluten challenge in coeliac disease (CD). The aim of this study was to investigate the presence of an immune reaction towards cytoskeleton structures such as actin filaments in CD.
METHODS: Eighty three antiendomysial antibody positive CD patients (52 children and 31 adults) were studied at our outpatient clinics from 1996 to 1998 using indirect immunofluorescence, ELISA, and western blotting for antiactin (AAA) and antitissue transglutaminase (TGA) antibodies before and after a gluten free diet (GFD). Sixteen patients with smooth muscle antibody positive autoimmune hepatitis, 21 with inflammatory bowel diseases, seven with small bowel bacterial overgrowth, and 60 healthy subjects were studied as controls.
RESULTS: Fifty nine of 83 CD patients (28/31 adults (90.3%); 31/52 children (59.6%)) were positive for IgA and/or IgG AAA. Seventy seven (92.7%) were positive for IgA TGA. IgA AAA were strongly correlated with more severe degrees of intestinal villous atrophy (p<0.0001; relative risk 86.17). After a GFD, AAA became undetectable within five months.
CONCLUSIONS: Apart from the immune reaction against the extracellular matrix, we have described an immune reaction against the cytoskeleton in both children and adults with CD. As AAA are strongly associated with more severe degrees of villous atrophy, they may represent a useful serological marker of severe intestinal atrophy in CD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986212      PMCID: PMC1728086          DOI: 10.1136/gut.47.4.520

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

Review 1.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

2.  Early biochemical responses of the small intestine of coeliac patients to wheat gluten.

Authors:  D S Bailey; A R Freedman; S C Price; D Chescoe; P J Ciclitira
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

3.  Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.

Authors:  A Fasano; T Not; W Wang; S Uzzau; I Berti; A Tommasini; S E Goldblum
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

4.  Smooth muscle antibodies of actin and "non-actin" specificity.

Authors:  P Kurki; E Linder; A Miettinen; O Alfthan
Journal:  Clin Immunol Immunopathol       Date:  1978-04

5.  Gliadin and reticulin antibodies in childhood coeliac disease.

Authors:  D J Unsworth; J A Walker-Smith; E J Holborow
Journal:  Lancet       Date:  1983-04-16       Impact factor: 79.321

6.  Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease.

Authors:  A Ventura; G Magazzù; L Greco
Journal:  Gastroenterology       Date:  1999-08       Impact factor: 22.682

7.  Elevated serum aminotransferase activity as an early manifestation of gluten-sensitive enteropathy.

Authors:  P Vajro; A Fontanella; M Mayer; A De Vincenzo; L M Terracciano; M D'Armiento; R Vecchione
Journal:  J Pediatr       Date:  1993-03       Impact factor: 4.406

8.  Effects of wheat germ agglutinin on the cellular content of filamentous actin in Intestine 407 cells.

Authors:  A Sjölander; K E Magnusson
Journal:  Eur J Cell Biol       Date:  1988-10       Impact factor: 4.492

9.  Hepatic injury in adult coeliac disease.

Authors:  B Hagander; N O Berg; L Brandt; A Nordén; K Sjölund; M Stenstam
Journal:  Lancet       Date:  1977-08-06       Impact factor: 79.321

10.  Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.

Authors:  L M Sollid; G Markussen; J Ek; H Gjerde; F Vartdal; E Thorsby
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  21 in total

1.  Anti-actin IgA antibodies in severe coeliac disease.

Authors:  A Granito; P Muratori; F Cassani; G Pappas; L Muratori; D Agostinelli; L Veronesi; R Bortolotti; N Petrolini; F B Bianchi; U Volta
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 2.  Cutting-edge issues in celiac disease and in gluten intolerance.

Authors:  N Bizzaro; R Tozzoli; D Villalta; M Fabris; E Tonutti
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 3.  Celiac disease: is the atypical really typical? Summary of the recent National Institutes of Health Consensus Conference and latest advances.

Authors:  Swati Gadewar; Alessio Fasano
Journal:  Curr Gastroenterol Rep       Date:  2005-12

Review 4.  Antibodies in celiac disease: implications beyond diagnostics.

Authors:  Sergio Caja; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

5.  Detection of autoantibodies against actin filaments in celiac disease.

Authors:  B Porcelli; F Ferretti; C Vindigni; C Scapellato; L Terzuoli
Journal:  J Clin Lab Anal       Date:  2013-01-04       Impact factor: 2.352

6.  Serological and clinical comparison of children and adults with anti-endomysial antibodies.

Authors:  Branka Bonaci-Nikolic; Sladjana Andrejevic; Nedeljko Radlovic; Ivana Davidovic; Ljiljana Sofronic; Milan Spuran; Marjan Micev; Milos M Nikolic
Journal:  J Clin Immunol       Date:  2007-01-23       Impact factor: 8.317

7.  IgA anti-actin antibodies in children with celiac disease: comparison of immunofluorescence with Elisa assay in predicting severe intestinal damage.

Authors:  Elena Bazzigaluppi; Barbara Parma; Giulia M Tronconi; Patrizia Corsin; Luca Albarello; Stefano Mora; Graziano Barera
Journal:  Ital J Pediatr       Date:  2010-03-18       Impact factor: 2.638

8.  A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits.

Authors:  R C W Wong; R J Wilson; R H Steele; G Radford-Smith; S Adelstein
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

9.  Anti-microbial antibodies in celiac disease: trick or treat?

Authors:  Maria Papp; Ildiko Foldi; Istvan Altorjay; Eszter Palyu; Miklos Udvardy; Judit Tumpek; Sandor Sipka; Ilma Rita Korponay-Szabo; Eva Nemes; Gabor Veres; Tamas Dinya; Attila Tordai; Hajnalka Andrikovics; Gary L Norman; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

10.  Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge.

Authors:  Marlou P M Adriaanse; Daniel A Leffler; Ciaran P Kelly; Detlef Schuppan; Robert M Najarian; Jeffrey D Goldsmith; Wim A Buurman; Anita C E Vreugdenhil
Journal:  Am J Gastroenterol       Date:  2016-05-17       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.